1. 1. Describe the test results to the subject;

2. 2. Provide or arrange for the subject to receive the following information about the STI for which the subject was tested:

   1. a. A description of the infection or syndrome caused by the STI, including its symptoms;
   2. b. Treatment options for the STI and where treatment may be obtained;
   3. c. A description of how the STI is transmitted to others;
   4. d. A description of measures to reduce the likelihood of transmitting the STI to others and that it is necessary to continue the measures until the infection is eliminated;
   5. e. That it is necessary for the subject to notify individuals who may have been infected by the subject that the individuals need to be tested for the STI;
   6. f. The availability of assistance from local health agencies or other resources; and
   7. g. The confidential nature of the subject’s test results;
3. 3. Report the information required in R9-6-202 to a local health agency; and
4. 4. If the subject is pregnant and is a syphilis case, inform the subject of the requirement that the subject obtain serologic testing for syphilis according to R9-6-391.

When a laboratory report for a test ordered by a health care provider for a subject indicates that the subject is infected with an STI, the ordering health care provider or the ordering health care provider’s designee shall:

Historical Note

New Section made by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2). Amended by final rulemaking at 23 A.A.R. 2605, effective January 1, 2018 (Supp. 17-3). Section amended by final expedited rulemaking at 29 A.A.R. 3633 (November 24, 2023), with an immediate effective date of November 8, 2023 (Supp. 23-4). Amended by final rulemaking at 31 A.A.R. 1317 (April 25, 2025), effective June 2, 2025 (Supp. 25-2).